ONEMEDNET CORPORATION Proceeds from Lines of Credit
ONEMEDNET CORPORATION (ONMD) reported Proceeds from Lines of Credit of $500.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2025-11-14
- ONEMEDNET CORPORATION proceeds from lines of credit for the quarter ending 2024-12-31 was $0.00.
- ONEMEDNET CORPORATION proceeds from lines of credit for the quarter ending 2024-09-30 was $0.00.
- ONEMEDNET CORPORATION proceeds from lines of credit for the quarter ending 2024-06-30 was $90.00K.
- ONEMEDNET CORPORATION proceeds from lines of credit for the quarter ending 2024-03-31 was $410.00K.
- ONEMEDNET CORPORATION proceeds from lines of credit for fiscal 2024 was $500.00K.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $90.00K derived: sum of 3 quarters · filed 2025-11-14 | $500.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $90.00K derived: sum of 2 quarters · filed 2025-11-14 | $500.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $500.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $410.00K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |